Frovocimab

DB15089Investigational

Frovocimab is under investigation in clinical trial NCT01671085 (A Study of LY3015014 in Healthy Participants With High Cholesterol).

Mechanism: Pharmacologically active on Proprotein convertase subtilisin/kexin type 9
Curator reviewed
Code names: LY3015014

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Frovocimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.